Developmental neurotoxicity of sedatives and anesthetics: A concern for neonatal and pediatric critical care medicine?

Pediatric Critical Care Medicine

Volumn 11, Issue 2, 2010, Pages 217-226

  Loepke, Andreas W ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Anesthesia; Anesthetics; Brain; GABA; Infant; Neonatal; Neuroapoptosis; Neurodegeneration; Neurotoxicity; Newborn; NMDA; Sedation; Sedatives

Indexed keywords

ANESTHETIC AGENT; CHLORAL HYDRATE; CLONAZEPAM; DEXMEDETOMIDINE; DIAZEPAM; ENFLURANE; HALOTHANE; ISOFLURANE; KETAMINE; LORAZEPAM; MIDAZOLAM; NITROUS OXIDE; PENTOBARBITAL; PHENOBARBITAL; PROPOFOL; SEDATIVE AGENT; SEVOFLURANE; THIOPENTAL; XENON;

ARTICLE; BRAIN DEVELOPMENT; CHICK; COGNITION; COGNITIVE DEFECT; COMORBIDITY; DEVELOPMENTAL DISORDER; DISEASE PREDISPOSITION; DOSE TIME EFFECT RELATION; DRUG EXPOSURE; INFORMATION RETRIEVAL; INTENSIVE CARE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROLOGIC DISEASE; NEUROTOXICITY; NEWBORN INTENSIVE CARE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SWINE;

EID: 77949483935     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3181b80383     Document Type: Review

References (142)

1. Carbajal R, Rousset A, Danan C, et al: Epidemiology and treatment of painful procedures in neonates in intensive care units. JAMA 2008; 300:60-70
2. Anand KJ, Hickey PR: Pain and its effects in the human neonate and fetus. N Engl J Med 1987; 317:1321-1329
3. Fitzgerald M, Millard C, McIntosh N: Cutaneous hypersensitivity following peripheral tissue damage in newborn infants and its reversal with topical anaesthesia. Pain 1989; 39:31-36
4. Johnston CC, Stevens BJ: Experience in a neonatal intensive care unit affects pain response. Pediatrics 1996; 98:925-930
5. Taddio A, Katz J, Ilersich AL, et al: Effect of neonatal circumcision on pain response during subsequent routine vaccination. Lancet 1997; 349:599-603
6. Twite MD, Rashid A, Zuk J, et al: Sedation, analgesia, and neuromuscular blockade in the pediatric intensive care unit: Survey of fellowship training programs. Pediatr Crit Care Med 2004; 5:521-532
7. Du W, Warrier I, Tutag Lehr V, et al: Changing patterns of drug utilization in a neonatal intensive care population. Am J Perinatol 2006; 23:279-285
8. Varju P, Katarova Z, Madarasz E, et al: GABA signalling during development: New data and old questions. Cell Tissue Res 2001; 305:239-246
9. de Lima AD, Opitz T, Voigt T: Irreversible loss of a subpopulation of cortical interneurons in the absence of glutamatergic network activity. Eur J Neurosci 2004; 19: 2931-2943
10. Olney JW, Young C, Wozniak DF, et al: Do pediatric drugs cause developing neurons to commit suicide? Trends Pharmacol Sci 2004; 25:135-139
11. Olney JW, Young C, Wozniak DF, et al: Anesthesia-induced developmental neuroapoptosis. Does it happen in humans? Anesthesiology 2004; 101:273-275
12. Anand KJ, Soriano SG: Anesthetic agents and the immature brain: Are these toxic or therapeutic? Anesthesiology 2004; 101: 527-530
13. Jevtovic-Todorovic V: General anesthetics and the developing brain: Friends or foes? J Neurosurg Anesthesiol 2005; 17:204-206
14. Soriano SG, Loepke AW: Let's not throw the baby out with the bath water: Potential neurotoxicity of anesthetic drugs in infants and children. J Neurosurg Anesthesiol 2005; 17: 207-209
15. Jevtovic-Todorovic V, Olney JW: PRO: Anesthesia- induced developmental neuroapoptosis: status of the evidence. Anesth Analg 2008; 106:1659-1663
16. Loepke AW, McGowan FX Jr, Soriano SG: CON: The toxic effects of anesthetics in the developing brain: The clinical perspective. Anesth Analg 2008; 106:1664-1669
17. Istaphanous GK, Loepke AW: General anesthetics and the developing brain. Curr Opin Anaesthesiol 2009; 22:368-373
18. Loepke AW, Soriano SG: An assessment of the effects of general anesthetics on developing brain structure and neurocognitive function. Anesth Analg 2008; 106: 1681-1707
19. Tobias JD: Sedation and analgesia in the pediatric intensive care unit. Pediatr Ann 2005; 34:636-645
20. Hammer GB: Sedation and analgesia in the pediatric intensive care unit following laryngotracheal reconstruction. Otolaryngol Clin North Am 2008; 41:1023-1044, x-xi
21. Ikonomidou C, Bosch F, Miksa M, et al: Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999; 283:70-74
22. Hayashi H, Dikkes P, Soriano SG: Repeated administration of ketamine may lead to neuronal degeneration in the developing rat brain. Paediatr Anaesth 2002; 12:770-774
23. Fredriksson A, Archer T: Hyperactivity following postnatal NMDA antagonist treatment: Reversal by D-amphetamine. Neurotox Res 2003; 5:549-564
24. Fredriksson A, Archer T, Alm H, et al: Neurofunctional deficits and potentiated apoptosis by neonatal NMDA antagonist administration. Behav Brain Res 2004; 153: 367-376
25. Fredriksson A, Archer T: Neurobehavioural deficits associated with apoptotic neurodegeneration and vulnerability for ADHD. Neurotox Res 2004; 6:435-456
26. Scallet AC, Schmued LC, Slikker W Jr, et al: Developmental neurotoxicity of ketamine: Morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons. Toxicol Sci 2004; 81: 364-370
27. Rudin M, Ben-Abraham R, Gazit V, et al: Single-dose ketamine administration induces apoptosis in neonatal mouse brain. J Basic Clin Physiol Pharmacol 2005; 16: 231-243
28. Wang C, Sadovova N, Fu X, et al: The role of the N-methyl-D-aspartate receptor in ketamine- induced apoptosis in rat forebrain culture. Neuroscience 2005; 132:967-977
29. Young C, Jevtovic-Todorovic V, Qin YQ, et al: Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain. Br J Pharmacol 2005; 146: 189-197
30. Wang C, Sadovova N, Hotchkiss C, et al: Blockade of N-methyl-D-aspartate receptors by ketamine produces loss of postnatal day 3 monkey frontal cortical neurons in culture. Toxicol Sci 2006; 91:192-201
31. Vutskits L, Gascon E, Tassonyi E, et al: Effect of ketamine on dendritic arbor development and survival of immature GABAergic neurons in vitro. Toxicol Sci 2006; 91: 540-549
32. Takadera T, Ishida A, Ohyashiki T: Ketamine- induced apoptosis in cultured rat cortical neurons. Toxicol Appl Pharmacol 2006; 210:100-107
33. Shang Y, Wu Y, Yao S, et al: Protective effect of erythropoietin against ketamineinduced apoptosis in cultured rat cortical neurons: Involvement of PI3K/Akt and GSK-3 beta pathway. Apoptosis 2007; 12: 2187-2195
34. Slikker W Jr, Zou X, Hotchkiss CE, et al: Ketamine-induced neuronal cell death in the perinatal rhesus monkey. Toxicol Sci 2007; 98:145-158
35. Vutskits L, Gascon E, Potter G, et al: Low concentrations of ketamine initiate dendritic atrophy of differentiated GABAergic neurons in culture. Toxicology 2007; 234: 216-226
36. Anand KJ, Garg S, Rovnaghi CR, et al: Ketamine reduces the cell death following inflammatory pain in newborn rat brain. Pediatr Res 2007; 62:283-290
37. Stevens MF, Werdehausen R, Gaza N, et al: Ketamine-induced apoptosis is not stereospecific and mediated via the mitochondrial pathway. Anesthesiology 2007; 107: A719
38. Fredriksson A, Ponten E, Gordh T, et al: Neonatal exposure to a combination of Nmethyl- D-aspartate and gamma-aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent behavioral deficits. Anesthesiology 2007; 107:427-436
39. Wang C, Sadovova N, Patterson TA, et al: Protective effects of 7-nitroindazole on ketamine- induced neurotoxicity in rat forebrain culture. Neurotoxicology 2008; 29: 613-620
40. Viberg H, Ponten E, Eriksson P, et al: Neonatal ketamine exposure results in changes in biochemical substrates of neuronal growth and synaptogenesis, and alters adult behavior irreversibly. Toxicology 2008; 249: 153-159
41. Rovnaghi CR, Garg S, Hall RW, et al: Ketamine analgesia for inflammatory pain in neonatal rats: A factorial randomized trial examining long-term effects. Behav Brain Funct 2008; 4:35
42. Boctor SY, Wang C, Ferguson SA: Neonatal PCP is more potent than ketamine at modifying preweaning behaviors of Sprague- Dawley rats. Toxicol Sci 2008; 106:172-179
43. Vutskits L, De Roo M, Klauser P, et al: Anesthetics impair dendritic spine development in the postnatal mouse somatosensory cortex. Anesthesiology 2008; 109:A325
44. Straiko MM, Young C, Cattano D, et al: Lithium protects against anesthesia-induced developmental neuroapoptosis. Anesthesiology 2009; 110:862-868
45. Zou X, Patterson TA, Sadovova N, et al: Potential neurotoxicity of ketamine in the developing rat brain. Toxicol Sci 2009; 108: 149-158
46. Ibla JC, Hayashi H, Bajic D, et al: Prolonged exposure to ketamine increases brain derived neurotrophic factor levels in developing rat brains. Curr Drug Saf 2009; 4:11-16
47. Ikonomidou C, Bittigau P, Ishimaru MJ, et al: Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 2000; 287:1056-1060
48. Bittigau P, Sifringer M, Genz K, et al: Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A 2002; 99:15089-15094
49. Stefovska VG, Uckermann O, Czuczwar M, et al: Sedative and anticonvulsant drugs suppress postnatal neurogenesis. Ann Neurol 2008; 64:434-445
50. Jevtovic-Todorovic V, Hartman RE, Izumi Y, et al: Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 2003; 23:876-882
51. Olney JW, Wang H, Qin Y, et al: Pilocarpine pretreatment reduces neuroapoptosis induced by midazolam or isoflurane in infant mouse brain. Program No 28615 2006 Neu- roscience Meeting Planner. Atlanta, GA, Society for Neuroscience, 2006
52. Yon JH, Daniel-Johnson J, Carter LB, et al: Anesthesia induces neuronal cell death in the developing rat brain via the intrinsic and extrinsic apoptotic pathways. Neuroscience 2005; 135:815-827
53. Vutskits L, Gascon E, Tassonyi E, et al: Clinically relevant concentrations of propofol but not midazolam alter in vitro dendritic development of isolated gammaaminobutyric acid-positive interneurons. Anesthesiology 2005; 102:970-976
54. Sanders RD, Xu J, Shu Y, et al: Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats. Anesthesiology 2009; 110:1077-1085
55. Cattano D, Straiko MM, Olney JW: Chloral hydrate induces and lithium prevents neuroapoptosis in the infant mouse brain. Anesthesiology 2008; 109:A315
56. Asimiadou S, Bittigau P, Felderhoff-Mueser U, et al: Protection with estradiol in developmental models of apoptotic neurodegeneration. Ann Neurol 2005; 58:266-276
57. Kim JS, Kondratyev A, Tomita Y, et al: Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain. Epilepsia 2007; 48(Suppl 5):19-26
58. Katz I, Kim J, Gale K, et al: Effects of lamotrigine alone and in combination with MK-801, phenobarbital, or phenytoin on cell death in the neonatal rat brain. J Pharmacol Exp Ther 2007; 322:494-500
59. Rothstein S, Simkins T, Nunez JL: Response to neonatal anesthesia: Effect of sex on anatomical and behavioral outcome. Neuroscience 2008; 152:959-969
60. Honegger P, Matthieu JM: Selective toxicity of the general anesthetic propofol for GABAergic neurons in rat brain cell cultures. J Neurosci Res 1996; 45:631-636
61. Spahr-Schopfer I, Vutskits L, Toni N, et al: Differential neurotoxic effects of propofol on dissociated cortical cells and organotypic hippocampal cultures. Anesthesiology 2000; 92:1408-1417
62. Al-Jahdari WS, Saito S, Nakano T, et al: Propofol induces growth cone collapse and neurite retractions in chick explant culture. Can J Anaesth 2006; 53:1078-1085
63. Cattano D, Young C, Straiko MM, et al: Subanesthetic doses of propofol induce neuroapoptosis in the infant mouse brain. Anesth Analg 2008; 106:1712-1714
64. Gressens P, Dingley J, Plaisant F, et al: Analysis of neuronal, glial, endothelial, axonal and apoptotic markers following moderate therapeutic hypothermia and anesthesia in the developing piglet brain. Brain Pathol 2008; 18:10-20
65. Kahraman S, Zup SL, McCarthy MM, et al: GABAergic mechanism of propofol toxicity in immature neurons. J Neurosurg Anesthesiol 2008; 20:233-240
66. Pesic V, Milanovic D, Tanic N, et al: Potential mechanism of cell death in the developing rat brain induced by propofol anesthesia. Int J Dev Neurosci 2009; 27:279-287
67. Ma D, Williamson P, Januszewski A, et al: Xenon mitigates isoflurane-induced neuronal apoptosis in the developing rodent brain. Anesthesiology 2007; 106:746-753
68. Rizzi S, Carter LB, Jevtovic-Todorovic V: Clinically used general anesthetics induce neuroapoptosis in the developing piglet brain. Program No 25172005 Abstract/ Viewer/Itinerary Planner. Washington, DC, Society for Neuroscience, 2005
69. Wise-Faberowski L, Zhang H, Ing R, et al: Isoflurane-induced neuronal degeneration: An evaluation in organotypic hippocampal slice cultures. Anesth Analg 2005; 101: 651-657
70. Wei H, Kang B, Wei W, et al: Isoflurane and sevoflurane affect cell survival and BCL-2/ BAX ratio differently. Brain Res 2005; 1037: 139-147
71. Lu LX, Yon JH, Carter LB, et al: General anesthesia activates BDNF-dependent neuroapoptosis in the developing rat brain. Apoptosis 2006; 11:1603-1615
72. Yon JH, Carter LB, Reiter RJ, et al: Melatonin reduces the severity of anesthesiainduced apoptotic neurodegeneration in the developing rat brain. Neurobiol Dis 2006; 21:522-530
73. Januszewski AP, Sanders RD, Halder S, et al: Alpha2 adrenoceptor agonism but not GABAA receptor antagonism can attenuate isoflurane neurotoxicity. Anesthesiology 2007; 107:A474
74. Wei H, Liang G, Yang H: Isoflurane preconditioning inhibited isoflurane-induced neurotoxicity. Neurosci Lett 2007; 425:59-62
75. Nikizad H, Yon JH, Carter LB, et al: Early exposure to general anesthesia causes significant neuronal deletion in the developing rat brain. Ann N Y Acad Sci 2007; 1122: 69-82
76. Rizzi S, Carter LB, Ori C, et al: Clinical anesthesia causes permanent damage to the fetal guinea pig brain. Brain Pathol 2008; 18:198-210
77. Johnson SA, Young C, Olney JW: Isoflurane- induced neuroapoptosis in the developing brain of nonhypoglycemic mice. J Neurosurg Anesthesiol 2008; 20:21-28
78. Sanders RD, Xu J, Shu Y, et al: General anesthetics induce apoptotic neurodegeneration in the neonatal rat spinal cord. Anesth Analg 2008; 106:1708-1711
79. Olney JW, Straiko MM, Cattano D, et al: Preventing anesthesia-induced developmental neuroapoptosis-Temperature regulation approach. Anesthesiology 2008; 109:A1414
80. Zou X, Sadovova N, Patterson TA, et al: The effects of L-carnitine on the combination of, inhalation anesthetic-induced developmental, neuronal apoptosis in the rat frontal cortex. Neuroscience 2008; 151:1053-1065
81. Wang QJ, Li KZ, Yao SL, et al: Different effects of isoflurane and sevoflurane on cytotoxicity. Chin Med J 2008; 121:341-346
82. Loepke AW, Istaphanous GK, McAuliffe JJ 3rd, et al: The effects of neonatal isoflurane exposure in mice on brain cell viability, adult behavior, learning, and memory. Anesth Analg 2009; 108:90-104
83. Head BP, Patel HH, Niesman IR, et al: Inhibition of p75 neurotrophin receptor attenuates isoflurane-mediated neuronal apoptosis in the neonatal central nervous system. Anesthesiology 2009; 110:813-825
84. Stratmann G, Sall JW, May LD, et al: Isoflurane differentially affects neurogenesis and long-term neurocognitive function in 60- day-old and 7-day-old rats. Anesthesiology 2009; 110:834-848
85. Stratmann G, May LD, Sall JW, et al: Effect of hypercarbia and isoflurane on brain cell death and neurocognitive dysfunction in 7-day-old rats. Anesthesiology 2009; 110: 849-861
86. Zhang X, Xue Z, Sun A: Subclinical concentration of sevoflurane potentiates neuronal apoptosis in the developing C57BL/6 mouse brain. Neurosci Lett 2008; 447:109-114
87. Uemura E, Bowman RE: Effects of halothane on cerebral synaptic density. Exp Neurol 1980; 69:135-142
88. Chalon J, Tang CK, Ramanathan S, et al: Exposure to halothane and enflurane affects learning function of murine progeny. Anesth Analg 1981; 60:794-797
89. Uemura E, Ireland WP, Levin ED, et al: Effects of halothane on the development of rat brain: A Golgi study of dendritic growth. Exp Neurol 1985; 89:503-519
90. Uemura E, Levin ED, Bowman RE: Effects of halothane on synaptogenesis and learning behavior in rats. Exp Neurol 1985; 89: 520-529
91. Uemura E, Levin ED, DeLuna R, et al: Suppressive effects of halothane on reactive synaptogenesis in the dentate gyrus of rats. Brain Res 1989; 496:317-320
92. Cattano D, Williamson P, Fukui K, et al: Potential of xenon to induce or to protect against neuroapoptosis in the developing mouse brain. Can J Anaesth 2008; 55: 429-436
93. Li Y, Liang G, Wang S, et al: Effects of fetal exposure to isoflurane on postnatal memory and learning in rats. Neuropharmacology 2007; 53:942-950
94. Playfor S, Jenkins I, Boyles C, et al: Consensus guidelines on sedation and analgesia in critically ill children. Intensive Care Med 2006; 32:1125-1136
95. Jenkins IA, Playfor SD, Bevan C, et al: Current United Kingdom sedation practice in pediatric intensive care. Paediatr Anaesth 2007; 17:675-683
96. Hall RW, Kronsberg SS, Barton BA, et al: Morphine, hypotension, and adverse outcomes among preterm neonates: Who's to blame? Secondary results from the NEOPAIN trial. Pediatrics 2005; 115: 1351-1359
97. Hall RW, Shbarou RM: Drugs of choice for sedation and analgesia in the neonatal ICU. Clin Perinatol 2009; 36:15-26
98. Hammer RP Jr, Ricalde AA, Seatriz JV: Effects of opiates on brain development. Neurotoxicology 1989; 10:475-483
99. Hu S, Sheng WS, Lokensgard JR, et al: Morphine induces apoptosis of human microglia and neurons. Neuropharmacology 2002; 42:829-836
100. Svensson AL, Bucht N, Hallberg M, et al: Reversal of opiate-induced apoptosis by human recombinant growth hormone in murine foetus primary hippocampal neuronal cell cultures. Proc Natl Acad Sci U S A 2008; 105:7304-7308
101. Tobias JD: Dexmedetomidine: Applications in pediatric critical care and pediatric anesthesiology. Pediatr Crit Care Med 2007; 8:115-131
102. Tobias JD: Therapeutic applications and uses of inhalational anesthesia in the pediatric intensive care unit. Pediatr Crit Care Med 2008; 9:169-179
103. Van Howe RS, Svoboda JS: Neonatal pain relief and the Helsinki Declaration. J Law Med Ethics 2008; 36:803- 823, 611
104. Grunau RE, Holsti L, Peters JW: Long-term consequences of pain in human neonates. Semin Fetal Neonatal Med 2006; 11: 268-275
105. Anand KJ, Brown MJ, Causon RC, et al: Can the human neonate mount an endocrine and metabolic response to surgery? J Pediatr Surg 1985; 20:41-48
106. Quinn MW, Wild J, Dean HG, et al: Randomised double-blind controlled trial of effect of morphine on catecholamine concentrations in ventilated pre-term babies. Lancet 1993; 342:324-327
107. Simons SH, van Dijk M, van Lingen RA, et al: Randomised controlled trial evaluating effects of morphine on plasma adrenaline/ noradrenaline concentrations in newborns. Arch Dis Child Fetal Neonatal Ed 2005; 90:F36-F40
108. Slater R, Cantarella A, Gallella S, et al: Cortical pain responses in human infants. J Neurosci 2006; 26:3662-3666
109. Abdulkader HM, Freer Y, Garry EM, et al: Prematurity and neonatal noxious events exert lasting effects on infant pain behaviour. Early Hum Dev 2008; 84:351-355
110. Walker SM, Franck LS, Fitzgerald M, et al: Long-term impact of neonatal intensive care and surgery on somatosensory perception in children born extremely preterm. Pain 2009; 141:79-87
111. Grunau RE, Whitfield MF, Petrie-Thomas J, et al: Neonatal pain, parenting stress and interaction, in relation to cognitive and motor development at 8 and 18 months in preterm infants. Pain 2009; 143:138-146
112. Ruda MA, Ling QD, Hohmann AG, et al: Altered nociceptive neuronal circuits after neonatal peripheral inflammation. Science 2000; 289:628-631
113. Solt K, Forman SA: Correlating the clinical actions and molecular mechanisms of general anesthetics. Curr Opin Anaesthesiol 2007; 20:300-306
114. Zimmermann KC, Green DR: How cells die: apoptosis pathways. J Allergy Clin Immunol 2001; 108:S99-103
115. McPherson RJ, Gleason C, Mascher-Denen M, et al: A new model of neonatal stress which produces lasting neurobehavioral effects in adult rats. Neonatology 2007; 92: 33-41
116. Boasen JF, McPherson RJ, Hays SL, et al: Neonatal stress or morphine treatment alters adult mouse conditioned place preference. Neonatology 2009; 95:230-239
117. Oppenheim RW: Cell death during development of the nervous system. Annu Rev Neurosci 1991; 14:453-501
118. Rakic S, Zecevic N: Programmed cell death in the developing human telencephalon. Eur J Neurosci 2000; 12:2721-2734
119. Kuida K, Zheng TS, Na S, et al: Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996; 384:368-372
120. Blomgren K, Leist M, Groc L: Pathological apoptosis in the developing brain. Apoptosis 2007; 12:993-1010
121. Huang CH, Wang YP, Wu PY, et al: Propofol infusion shortens and attenuates oxidative stress during one lung ventilation. Acta Anaesthesiol Taiwan 2008; 46:160-165
122. Eichbaum FW, Yasaka WJ: Antiarrhythmic effect of solvents: Propylene glycol, benzyl alcohol. Basic Res Cardiol 1976; 71: 355-370
123. Shehab N, Lewis CL, Streetman DD, et al: Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. Pediatr Crit Care Med 2009; 10:256-259
124. Dobbing J: The later development of the brain and its vulnerability. In: Scientific Foundations of Paediatrics. Davis JA, Dobbing J (Eds). London, Heinemann Medical, 1991, pp 744-759
125. Dekaban AS: Changes in brain weights during the span of human life: Relation of brain weights to body heights and body weights. Ann Neurol 1978; 4:345-356
126. Clancy B, Finlay BL, Darlington RB, et al: Extrapolating brain development from experimental species to humans. Neurotoxicology 2007; 28:931-937
127. Morford LL, Henck JW, Breslin WJ, et al: Hazard identification and predictability of children's health risk from animal data. Environ Health Perspect 2004; 112:266-271
128. Prins S, van Dijk M, Tibboel D: Sedation and analgesia in the PICU: Many questions remain. Intensive Care Med 2006; 32: 1103-1105
129. Tobias JD: Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit. Crit Care Med 2000; 28:2122-2132
130. Tempel A: Visualization of mu opiate receptor downregulation following morphine treatment in neonatal rat brain. Brain Res Dev Brain Res 1991; 64:19-26
131. Thornton SR, Smith FL: Long-term alterations in opiate antinociception resulting from infant fentanyl tolerance and dependence. Eur J Pharmacol 1998; 363:113-119
132. Bhutta AT, Cleves MA, Casey PH, et al: Cognitive and behavioral outcomes of schoolaged children who were born preterm: a meta-analysis. JAMA 2002; 288:728-737
133. Hintz SR, Kendrick DE, Vohr BR, et al: Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999. Pediatrics 2005; 115:1645-1651
134. Larroque B, Ancel PY, Marret S, et al: Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): A longitudinal cohort study. Lancet 2008; 371:813-820
135. Hintz SR, Kendrick DE, Stoll BJ, et al: Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics 2005; 115:696-703
136. DiMaggio CJ, Sun L, Kakavouli A, et al: Exposure to anesthesia and the risk of developmental and behavioral disorders in young children. Anesthesiology 2008; 109: A1415
137. Wilder RT, Flick RP, Sprung J, et al: Early exposure to anesthesia and learning disabilities in a population-based birth cohort. Anesthesiology 2009; 110:796-804
138. Kalkman CJ, Peelen L, Moons KG, et al: Behavior and development in children and age at the time of first anesthetic exposure. Anesthesiology 2009; 110:805-812
139. Anand KJ, Hall RW, Desai N, et al: Effects of morphine analgesia in ventilated preterm neonates: Primary outcomes from the NEOPAIN randomised trial. Lancet 2004; 363:1673-1682
140. Rao R, Sampers JS, Kronsberg SS, et al: Neurobehavior of preterm infants at 36 weeks postconception as a function of morphine analgesia. Am J Perinatol 2007; 24: 511-517
141. MacGregor R, Evans D, Sugden D, et al: Outcome at 5-6 years of prematurely born children who received morphine as neonates. Arch Dis Child Fetal Neonatal Ed 1998; 79:F40-43
142. Rozé JC, Denizot S, Carbajal R, et al: Prolonged sedation and/or analgesia and 5-year neurodevelopment outcome in very preterm infants: Results from the EPIPAGE cohort. Arch Pediatr Adolesc Med 2008; 162:728-733